TrialOxidative medicine and cellular longevity2017

The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.

Bożena Adamczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.